Drugs / Calcium Levofolinate Hydrateb
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT06547385 Background | Jan 2021 → Oct 2027 expected | colorectal cancer | Ono Pharmaceutical Co., Ltd. | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Calcium Levofolinate Hydrateb | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06547385 ↗ |